EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma

NCT01192464 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: autologous CAR.CD30 EBV specific-CTLs

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]